{"title":"位于肿瘤侵袭前区的高has1癌相关成纤维细胞通过ECM重塑促进口腔鳞状细胞癌的侵袭。","authors":"Wanyong Jin, Qiuya Yu, Liyuan Yu, Ting Zhou, Xiren Wang, Wanqiu Lu, Xiaoxin Zhang, Liang Ding, Qingang Hu, Yanhong Ni","doi":"10.1186/s13046-025-03493-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although tumor cell heterogeneity between the tumor center (TC) and invasion front (IF) of oral squamous cell carcinoma (OSCC) is well documented, the morphological, molecular, and functional characteristics of cancer-associated fibroblasts (CAFs) in these regions remain poorly understood.</p><p><strong>Methods: </strong>We examined hematoxylin and eosin (H&E)-stained OSCC sections to assess CAF morphology and correlation with patient prognosis. We then isolated paired CAFs from the tumor center (CAF<sup>TC</sup>) and invasion front (CAF<sup>IF</sup>) of four OSCC patients and compared their ECM-remodeling activity and pro-tumorigenic effects on OSCC cells. Furthermore, RNA sequencing identified differentially expressed genes between CAF<sup>TC</sup> and CAF<sup>IF</sup>. Finally, based on RNA-seq findings, we knocked down hyaluronan synthase 1 (HAS1) in CAF<sup>IF</sup> to evaluate its role in extracellular matrix (ECM) remodeling and tumor invasion.</p><p><strong>Results: </strong>Compared to CAF<sup>TC</sup>, CAF<sup>IF</sup> exhibited a plump cell morphology and were associated with shorter disease-free survival. Functionally, CAF<sup>IF</sup> showed higher ECM-remodeling activity and more effective ability for promoting OSCC invasion and lymph node metastasis than CAF<sup>TC</sup>. RNA-seq identified HAS1 was significantly upregulated in CAF<sup>IF</sup>, promoting hyaluronic acid (HA) production and ECM remodeling. HAS1 knockdown in CAF<sup>IF</sup> diminished ECM remodeling and attenuated the ability of CAF<sup>IF</sup> to promoting OSCC invasion.</p><p><strong>Conclusion: </strong>CAF<sup>IF</sup> with plump cell morphology showed pro-invasive abilities, driven in part by HAS1 overexpression and ECM remodeling, suggesting that targeting HAS1-driven ECM remodeling could be a promising therapeutic strategy.</p>","PeriodicalId":50199,"journal":{"name":"Journal of Experimental & Clinical Cancer Research","volume":"44 1","pages":"238"},"PeriodicalIF":12.8000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351772/pdf/","citationCount":"0","resultStr":"{\"title\":\"HAS1<sup>high</sup> cancer associated fibroblasts located at the tumor invasion front zone promote oral squamous cell carcinoma invasion via ECM remodeling.\",\"authors\":\"Wanyong Jin, Qiuya Yu, Liyuan Yu, Ting Zhou, Xiren Wang, Wanqiu Lu, Xiaoxin Zhang, Liang Ding, Qingang Hu, Yanhong Ni\",\"doi\":\"10.1186/s13046-025-03493-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although tumor cell heterogeneity between the tumor center (TC) and invasion front (IF) of oral squamous cell carcinoma (OSCC) is well documented, the morphological, molecular, and functional characteristics of cancer-associated fibroblasts (CAFs) in these regions remain poorly understood.</p><p><strong>Methods: </strong>We examined hematoxylin and eosin (H&E)-stained OSCC sections to assess CAF morphology and correlation with patient prognosis. We then isolated paired CAFs from the tumor center (CAF<sup>TC</sup>) and invasion front (CAF<sup>IF</sup>) of four OSCC patients and compared their ECM-remodeling activity and pro-tumorigenic effects on OSCC cells. Furthermore, RNA sequencing identified differentially expressed genes between CAF<sup>TC</sup> and CAF<sup>IF</sup>. Finally, based on RNA-seq findings, we knocked down hyaluronan synthase 1 (HAS1) in CAF<sup>IF</sup> to evaluate its role in extracellular matrix (ECM) remodeling and tumor invasion.</p><p><strong>Results: </strong>Compared to CAF<sup>TC</sup>, CAF<sup>IF</sup> exhibited a plump cell morphology and were associated with shorter disease-free survival. Functionally, CAF<sup>IF</sup> showed higher ECM-remodeling activity and more effective ability for promoting OSCC invasion and lymph node metastasis than CAF<sup>TC</sup>. RNA-seq identified HAS1 was significantly upregulated in CAF<sup>IF</sup>, promoting hyaluronic acid (HA) production and ECM remodeling. HAS1 knockdown in CAF<sup>IF</sup> diminished ECM remodeling and attenuated the ability of CAF<sup>IF</sup> to promoting OSCC invasion.</p><p><strong>Conclusion: </strong>CAF<sup>IF</sup> with plump cell morphology showed pro-invasive abilities, driven in part by HAS1 overexpression and ECM remodeling, suggesting that targeting HAS1-driven ECM remodeling could be a promising therapeutic strategy.</p>\",\"PeriodicalId\":50199,\"journal\":{\"name\":\"Journal of Experimental & Clinical Cancer Research\",\"volume\":\"44 1\",\"pages\":\"238\"},\"PeriodicalIF\":12.8000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351772/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Experimental & Clinical Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s13046-025-03493-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental & Clinical Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13046-025-03493-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
HAS1high cancer associated fibroblasts located at the tumor invasion front zone promote oral squamous cell carcinoma invasion via ECM remodeling.
Background: Although tumor cell heterogeneity between the tumor center (TC) and invasion front (IF) of oral squamous cell carcinoma (OSCC) is well documented, the morphological, molecular, and functional characteristics of cancer-associated fibroblasts (CAFs) in these regions remain poorly understood.
Methods: We examined hematoxylin and eosin (H&E)-stained OSCC sections to assess CAF morphology and correlation with patient prognosis. We then isolated paired CAFs from the tumor center (CAFTC) and invasion front (CAFIF) of four OSCC patients and compared their ECM-remodeling activity and pro-tumorigenic effects on OSCC cells. Furthermore, RNA sequencing identified differentially expressed genes between CAFTC and CAFIF. Finally, based on RNA-seq findings, we knocked down hyaluronan synthase 1 (HAS1) in CAFIF to evaluate its role in extracellular matrix (ECM) remodeling and tumor invasion.
Results: Compared to CAFTC, CAFIF exhibited a plump cell morphology and were associated with shorter disease-free survival. Functionally, CAFIF showed higher ECM-remodeling activity and more effective ability for promoting OSCC invasion and lymph node metastasis than CAFTC. RNA-seq identified HAS1 was significantly upregulated in CAFIF, promoting hyaluronic acid (HA) production and ECM remodeling. HAS1 knockdown in CAFIF diminished ECM remodeling and attenuated the ability of CAFIF to promoting OSCC invasion.
Conclusion: CAFIF with plump cell morphology showed pro-invasive abilities, driven in part by HAS1 overexpression and ECM remodeling, suggesting that targeting HAS1-driven ECM remodeling could be a promising therapeutic strategy.
期刊介绍:
The Journal of Experimental & Clinical Cancer Research is an esteemed peer-reviewed publication that focuses on cancer research, encompassing everything from fundamental discoveries to practical applications.
We welcome submissions that showcase groundbreaking advancements in the field of cancer research, especially those that bridge the gap between laboratory findings and clinical implementation. Our goal is to foster a deeper understanding of cancer, improve prevention and detection strategies, facilitate accurate diagnosis, and enhance treatment options.
We are particularly interested in manuscripts that shed light on the mechanisms behind the development and progression of cancer, including metastasis. Additionally, we encourage submissions that explore molecular alterations or biomarkers that can help predict the efficacy of different treatments or identify drug resistance. Translational research related to targeted therapies, personalized medicine, tumor immunotherapy, and innovative approaches applicable to clinical investigations are also of great interest to us.
We provide a platform for the dissemination of large-scale molecular characterizations of human tumors and encourage researchers to share their insights, discoveries, and methodologies with the wider scientific community.
By publishing high-quality research articles, reviews, and commentaries, the Journal of Experimental & Clinical Cancer Research strives to contribute to the continuous improvement of cancer care and make a meaningful impact on patients' lives.